Fairmount Funds Management LLC

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 42% 68% 82%
Transactions
20 90% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 312%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Fairmount Funds Management LLC's trades of Crescent Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-20 2026-07-16
B Purchase
97,217 +19.9%
167.57
US$3,335,894 		97,217 +19.9% 167.57 US$3,335,894
2026-07-01 2026-07-01
PrS Proposed sale
60,997
460.72
US$1,268,337 		60,997 460.72 US$1,268,337
2026-07-01 2026-07-01
S Sale
4,810 -30.3%
482.72
US$2,939,019 		4,810 -30.3% 482.72 US$2,939,019
2026-06-23 2026-06-23
PrS Proposed sale
4,684,781
85.31
US$399,658,667 		4,684,781 85.31 US$399,658,667
2026-06-23 2026-06-23
S Sale
4,684,781 -100.0%
85.31
US$399,658,667 		4,684,781 -100.0% 85.31 US$399,658,667
2026-05-13 2026-05-11
B Purchase
1,176,470 +30.1%
17.00
US$19,999,990 		1,176,470 +30.1% 17.00 US$19,999,990
2026-04-01 2026-03-31
B Purchase
150,000 +6.8%
20.00
US$3,000,000 		150,000 +6.8% 20.00 US$3,000,000
2026-03-31 2026-03-31
S Sale
7,000,000 -56.0%
34.66
US$242,620,000 		7,000,000 -56.0% 34.66 US$242,620,000
2026-03-31 2026-03-31
PrS Proposed sale
7,000,000
34.66
US$242,620,000 		7,000,000 34.66 US$242,620,000
2026-01-22 2026-01-22
PrS Proposed sale
3,500,000
36.40
US$127,400,000 		3,500,000 36.40 US$127,400,000
2026-01-22 2026-01-22
PrS Proposed sale
1,750,000
76.30
US$133,525,000 		1,750,000 76.30 US$133,525,000
2026-01-22 2026-01-22
S Sale
1,750,000 -85.4%
76.30
US$133,525,000 		1,750,000 -85.4% 76.30 US$133,525,000
2026-01-22 2026-01-22
S Sale
3,500,000 -38.9%
36.40
US$127,400,000 		3,500,000 -38.9% 36.40 US$127,400,000
2025-12-08 2025-12-04
B Purchase
1,360,000 +98.0%
13.41
US$18,237,600 		1,360,000 +98.0% 13.41 US$18,237,600
2025-10-27 2025-10-23
B Purchase
454,545 +13.1%
22.00
US$9,999,990 		454,545 +13.1% 22.00 US$9,999,990
2025-10-09 2025-10-07
B Purchase
316,219 +16.7%
19.00
US$6,008,161 		316,219 +16.7% 19.00 US$6,008,161
2025-07-14 2025-07-10
B Purchase
2,777,777 +44.6%
9.00
US$24,999,993 		2,777,777 +44.6% 9.00 US$24,999,993
2024-09-16 2024-09-16
B Purchase
300,000 +23.0%
17.00
US$5,100,000 		300,000 +23.0% 17.00 US$5,100,000
2024-09-17 2024-09-13
B Purchase
1,600,000 +86.7%
18.75
US$30,000,000 		1,600,000 +86.7% 18.75 US$30,000,000
2024-01-24 2024-01-22
B Purchase
476,190 +34.9%
21.00
US$9,999,990 		476,190 +34.9% 21.00 US$9,999,990
2023-10-03 2023-09-29
B Purchase
24,670 +1.3%
13.63
US$336,252 		24,670 +1.3% 13.63 US$336,252
2023-09-28 2023-09-26
B Purchase
30,000 +1.6%
13.15
US$394,500 		30,000 +1.6% 13.15 US$394,500
2023-09-21 2023-09-19
B Purchase
30,000 +1.6%
13.20
US$396,000 		30,000 +1.6% 13.20 US$396,000
2023-09-13 2023-09-13
B Purchase
9,367 +0.5%
11.76
US$110,156 		9,367 +0.5% 11.76 US$110,156
2023-09-13 2023-09-12
B Purchase
14,887 +0.8%
10.85
US$161,524 		14,887 +0.8% 10.85 US$161,524
2023-07-17 2023-07-13
B Purchase
892,529 +inf%
17.00
US$15,172,993 		892,529 +inf% 17.00 US$15,172,993
2023-07-17 2023-07-13
B Purchase
1,992,734 +inf%
17.00
US$33,876,478 		1,992,734 +inf% 17.00 US$33,876,478
2023-07-17 2023-07-13
B Purchase
55,913 +inf%
17.00
US$950,521 		55,913 +inf% 17.00 US$950,521
2023-06-13 2023-06-09
B Purchase
800,000 +32.4%
12.00
US$9,600,000 		800,000 +32.4% 12.00 US$9,600,000
2022-08-19 2022-08-17
B Purchase
425,531 +45.4%
23.50
US$9,999,978 		425,531 +45.4% 23.50 US$9,999,978
2022-06-21 2022-06-16
B Purchase
1,200,000 +94.3%
8.25
US$9,900,000 		1,200,000 +94.3% 8.25 US$9,900,000